Corebridge Financial Inc. Sells 2,826 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Corebridge Financial Inc. trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 5.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,128 shares of the medical device company’s stock after selling 2,826 shares during the quarter. Corebridge Financial Inc.’s holdings in Cooper Companies were worth $4,332,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies during the 4th quarter worth approximately $33,000. OFI Invest Asset Management bought a new stake in Cooper Companies in the fourth quarter worth $34,000. West Financial Advisors LLC bought a new position in Cooper Companies during the fourth quarter valued at $49,000. Atala Financial Inc purchased a new position in shares of Cooper Companies in the 4th quarter worth $51,000. Finally, UMB Bank n.a. increased its holdings in shares of Cooper Companies by 22.5% in the 4th quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock worth $71,000 after buying an additional 142 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

COO stock opened at $83.77 on Monday. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The firm has a market cap of $16.75 billion, a price-to-earnings ratio of 42.96, a PEG ratio of 2.25 and a beta of 1.02. The business’s fifty day simple moving average is $89.33 and its two-hundred day simple moving average is $97.21. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of analyst reports. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.